GILEAD SCIENCES, INC. is 21.2x more valuable than REPLIGEN CORP by market capitalization ($155.93 B vs $7.37 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RGEN | GILD |
|---|---|---|
| Market cap | $7.37 B | $155.93 B |
| US-listed rank | #1137 | #98 |
| Revenue (latest FY) | $738.26M | $29.44B |
| Net income (latest FY) | $48.89M | $8.51B |
| Net margin | 6.6% | 28.9% |
| P/E (trailing FY) | 150.7 | 18.3 |
| SEC filings | 1,331 | 981 |
GILEAD SCIENCES, INC. is 21.2x more valuable than REPLIGEN CORP by market capitalization ($155.93 B vs $7.37 B).
In their latest fiscal years, REPLIGEN CORP reported $738.26M in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: REPLIGEN CORP and GILEAD SCIENCES, INC., or browse the full rankings.